Searchable abstracts of presentations at key conferences in endocrinology

ea0004s12 | Ageing and cellular senescence | SFE2002

Growth Hormone and Ageing

Sonksen P

Growth hormone (GH) secretion peaks in early adult life and declines progressively with age. People over the age of 60 have levels of GH secretion comparable to those in younger people with severe GH deficiency from pituitary tumours or their treatment. GH-dependent markers such as IGF-I, BP3, ALS and the collagen markers P-III-P, PICP, ITCP and osteocalcin all fall with age in parallel with the fall in GH secretion. Although exercise is one of the major stimuli to GH secretio...

ea0029oc18.3 | Paediatric Endocrinology | ICEECE2012

Effects of vitamin D insufficiency and its correction on insulin sensitivity and serum osteocalcin concentration in obese children

Nantarakchaikul P. , Poomthavorn P. , Mahochoklertwattana P. , Khlairit P. , Chailurkit L.

Background: Vitamin D insufficiency (VDI) was reported to be associated with decreased insulin sensitivity (IS). Individuals with higher osteocalcin (OC) were shown to have better IS. Vitamin D regulates OC synthesis. Obese children carry an abnormal glucose homeostasis risk. Whether correction of VDI improves IS in obese children and mediates such effect via OC are unclear. We, therefore, studied glucose homeostasis, IS, vitamin D status and serum OC concentration in 230 obes...

ea0029s28.3 | Osteoporosis treatment in 2012 and beyond | ICEECE2012

Other emerging therapies

Ebeling P.

Current osteoporosis therapy is predominantly ‘anti-resorptive’. Oestrogen antagonises the action of RANK-Ligand, a potent cytokine for osteoclast differentiation. Amino-bisphosphonates inhibit the HMG CoA reductase pathway, reducing osteoclast activity and viability, while denosumab is a human monoclonal antibody that binds to RANKL. Denosumab treatment reduces fractures. In a study of 7868 women with postmenopausal osteoporosis, denosumab reduced new radiographic v...

ea0071011 | Multiple endocrine neoplasia type 1: a single center-based series | BES2020

Multiple endocrine neoplasia type 1: A single center-based series

P Delannoy , P Petrossians , A Beckers

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the MEN1 gene (a tumor supressor gene) leading to the development of endocrine and non-endocrine tumours with variable penetrance.The most frequent features are primary hyperparathyroidism, duodeno pancreatic endocrine tumours and pituitary adenomas.Aim of the work: The aim of this retrospective study was to establish the pre...

ea0004p35 | Cytokines and growth factors | SFE2002

Paracrine IGF-I expression in the colon is associated with elevations of tumourigenic genes

Kelly P , Ogunkolade B , Fairclough P , Bustin S , Jenkins P

Introduction: The GH/IGF-I axis is implicated in colorectal cancer development. We have previously shown regional variations of the GH/IGF-I axis, and other tumour associated genes between the rectum (RS) and caecum (C). Whether variations in the GH/IGF-I axis align with differing expression patterns is unknown.Aim: To determine the association between colonic expression of the GH/IGF-I axis and that of tumour associated genes by region.<p class="abs...

ea0065pl4 | Society for Endocrinology Transatlantic Medal Lecture | SFEBES2019

How is alkaline phosphatase essential for bone? The transatlantic stories

Whyte Michael P

Alkaline phosphatase (ALP) was discovered by Robert Robison, PhD in London in 1923. In New York in 1932, he added to his hypothesis that ALP functioned in skeletal calcification by liberating inorganic phosphate (Pi) for hydroxyapatite crystal formation, perhaps from a hexosephosphoric ester, some unknown factor also conditioning this process. In 1948 in Toronto, Canada, ‘hypophosphatasia’ (HPP) was coined by John C. Rathbun, MD to describe a unique rickets without r...

ea0016gh1biog | The Geoffrey Harris Prize Lecture | ECE2008

Geoffrey Harris Prize Lecture

Chrousos George P

This prestigious prize is intended for established workers in the field of basic or clinical neuroendocrinology, and is generously support by Ipsen. This year's recipient is Professor George P Chrousos. The prize will be presented as part of the ECE 2008 opening ceremony where Professor Chrousos will deliver his lecture. Professor Chrousos will also give two other lectures at future ESE scientific meetings. Further information can be found at <a href="http://www...

ea0005p230 | Steroids | BES2003

Beneficial affects of regular exercise: Is it all in the hormones?

Andrews R , Wood P

Background: Diabetes increases the risk of developing coronary heart disease irrespective of glycaemic control. Cortisol and growth hormone (GH) abnormalities have been found in these patients and have been proposed as possible mechanisms for this increased risk.Regular exercise, through an unknown mechanism, can modify cardiovascular risk and so prevent or delay the progression of coronary heart disease. In this study we assessed whether an exercise program would a...

ea0021pl8biog | Clinical Endocrinology Trust Lecture | SFEBES2009

Clinical Endocrinology Trust Lecture

Clayton P E

P E Clayton, Endocrinology and Diabetes Group, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK AbstractPeter Clayton is Professor of Child Health and Paediatric Endocrinology in the Faculty of Medical and Human Sciences at the University of Manchester. He is an honorary consultant at the Royal Manchester Children’s Hospital and at the Christie Hospital and is the Director of t...

ea0029p1664 | Thyroid (non-cancer) | ICEECE2012

Prevalence, risk and clinical features of subclinical hyperthyroidism in patients with type 2 diabetes

Diez J. , Iglesias P.

Introduction: Both subclinical hyperthyroidism and type 2 diabetes (T2D) have been associated with an increase in cardiovascular disease risk and mortality. We aimed to assess the prevalence of newly diagnosed subclinical hyperthyroidism in a cohort of patients with T2D, and also to analyse the relationships between diabetes-related characteristics and the presence of subclinical hyperthyroidism.Methods: Nine hundred and thirty-three diabetic patients wi...